Biolife Solutions (BLFS) Cash from Financing Activities (2016 - 2025)
Biolife Solutions (BLFS) has disclosed Cash from Financing Activities for 16 consecutive years, with -$2.5 million as the latest value for Q4 2025.
- Quarterly Cash from Financing Activities rose 38.91% to -$2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$10.9 million through Dec 2025, down 61.05% year-over-year, with the annual reading at -$10.9 million for FY2025, 61.05% down from the prior year.
- Cash from Financing Activities for Q4 2025 was -$2.5 million at Biolife Solutions, up from -$2.6 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $17.4 million in Q3 2022, with the low at -$4.1 million in Q4 2024.
- Average Cash from Financing Activities over 5 years is $321100.0, with a median of -$767500.0 recorded in 2021.
- The sharpest move saw Cash from Financing Activities surged 1745.65% in 2022, then plummeted 308.81% in 2025.
- Over 5 years, Cash from Financing Activities stood at -$2.1 million in 2021, then skyrocketed by 70.31% to -$625000.0 in 2022, then soared by 1674.56% to $9.8 million in 2023, then crashed by 141.52% to -$4.1 million in 2024, then soared by 38.91% to -$2.5 million in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$2.5 million, -$2.6 million, and -$2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.